Gracell Biotechnologies Inc. (GRCL) Income Annual - Discounting Cash Flows
GRCL
Gracell Biotechnologies Inc.
GRCL (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
Report Filing 2023-09-30 2023-04-25 2022-04-22 2021-04-23 2019-12-31 2018-12-31
Revenue 0 0 0.366 0 0 0
Cost of Revenue 0 0 0 0 0 0
Gross Profit 0 0 0.366 0 0 0
Operating Expenses 578.8 624.7 463.9 214.4 146.6 62.5
Research & Development 444.5 485.4 326.9 168.8 119.2 52.24
Selling, General and Administrative 134.3 139.3 137 45.57 27.36 10.26
Other Operating Expenses 0 0 0 0 0 0
Operating Income -578.8 -624.7 -463.6 -214.4 -146.6 -62.5
Net Non-Operating Interest 38.5 17.18 4.05 0.715 3.93 1.44
Interest Income 44.94 23.92 9.12 2.87 3.93 1.44
Interest Expense 6.44 6.74 5.06 2.15 0 0
Equity & Other Income/(Expense) 43.41 -0.009 7.77 1.78 3.98 0.276
Income Before Tax -496.9 -607.5 -451.8 -211.9 -138.7 -60.79
Income Tax Expense 0.061 0.022 0 -14.74 -6.49 0
Income Attributable to Non-Controlling Interest 0 0 14.13 0 0 0
Net Income -497 -607.5 -465.9 -197.2 -132.2 -60.79
Depreciation and Amortization 53.64 32.08 78.45 7.57 2.57 2.99
EBITDA -525.2 -592.6 -385.1 -206.8 -144 -59.51
Earnings Per Share (EPS) -35.65 -44.85 -35.4 -15.05 -33.35 -15.35
Diluted Earnings Per Share -35.65 -44.85 -35.4 -15.05 -33.35 -15.35
Weighted Average Shares Outstanding 16.78 13.54 13.15 13.11 3.96 3.96
Diluted Weighted Average Shares Outstanding 16.78 13.54 13.15 13.11 3.96 3.96
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program